Orchid

About:

Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.

Website: https://www.orchidhealth.com/

Twitter/X: orchidinc

Top Investors: Elad Gil, Balaji Srinivasan, Village Global, Pebblebed, Refactor

Description:

Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed with world-class experts in reproductive medicine and genetics to give its clients the most accurate results. Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Total Funding Amount:

$16.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2019-01-01

Contact Email:

support(AT)orchidhealth.com

Founders:

Noor Siddiqui

Number of Employees:

11-50

Last Funding Date:

2023-12-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai